• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Orphanet journal of rare diseases >Reaching multidisciplinary consensus on classification of anaphylaxis for the eleventh revision of the World Health Organization's (WHO) International Classification of Diseases (ICD-11)
【24h】

Reaching multidisciplinary consensus on classification of anaphylaxis for the eleventh revision of the World Health Organization's (WHO) International Classification of Diseases (ICD-11)

机译：在世界卫生组织（WHO）国际疾病分类（ICD-11）第十一次修订中就过敏反应的分类达成多学科共识

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

BackgroundAlthough currently misclassified in the International Classification of Diseases (ICD) and still not officially listed as a rare disease, anaphylaxis is a well-known clinical emergency. Anaphylaxis is now one of the principal headings in the “Allergic and hypersensitivity conditions” section recently compiled for the forthcoming 11th Revision of ICD (ICD-11). We here report the building process used for the pioneering “Anaphylaxis” subsection of ICD-11 in which we aimed for transparency as recommended in the ICD-11 revision guidelines. ResultsDuring an online intensive scientific and technical discussions with ICD-11 Topic Advisory Groups and Expert Working Groups, we drafted a total of 35 proposals for the classification of anaphylaxis. From all the 35 proposals, 77% were implemented, 20% remain to be implemented, and the others being partially implemented (1.5%) or rejected (1.5%). ConclusionFor the first time, anaphylaxis is now properly classified and has attained greater visibility within ICD. In addition to all the benefits expected from the actions we have undertaken in updating the terminology, definitions and classification of allergic and hypersensitivity conditions for ICD-11, we strongly believe that anaphylaxis should be a public health priority and that it should therefore be formally added into the list of rare diseases in order to support awareness and quality clinical management of patients.
机译：背景技术尽管目前在国际疾病分类（ICD）中分类错误，并且仍未正式列为罕见疾病，但过敏反应是众所周知的临床急症。现在，过敏性反应是“过敏和超敏性疾病”部分的主要标题之一，该部分最近针对即将出版的ICD的第11版修订（ICD-11）进行了编辑。我们在这里报告了ICD-11开创性的“过敏反应”小节所用的构建过程，在该过程中，我们旨在实现ICD-11修订指南中建议的透明性。结果在与ICD-11主题咨询小组和专家工作小组进行的在线深入科学和技术讨论期间，我们共起草了35种过敏反应分类建议。在全部35项提案中，有77％已落实，有20％尚待落实，其余部分已部分落实（1.5％）或被拒绝（1.5％）。结论现在，过敏症首次被正确分类，并在ICD中获得了更大的知名度。除了我们为更新ICD-11过敏性和超敏性疾病的术语，定义和分类所采取的行动所期望的所有好处外，我们坚信过敏反应应作为公共卫生的重点，因此应正式添加纳入罕见病清单，以支持患者的意识和高质量的临床管理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号